Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion
Go back to Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 58.13 +2.32 (4.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.81 | 52 Week High | $77.12 | |||
| Open | $56.65 | 52 Week Low | $49.03 | |||
| Day High | $58.14 | P/E | 37.75 | |||
| Day Low | $56.41 | EPS | $1.54 | |||
| Volume | 10,003,974 | |||||
| (NASDAQ: KRTX) | Delayed: 329.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $329.83 | 52 Week High | $ | |||
| Open | $25.31 | 52 Week Low | $ | |||
| Day High | $329.83 | P/E | N/A | |||
| Day Low | $329.83 | EPS | $ | |||
| Volume | 9 | |||||
